Skye Bioscience SKYE Stock
Skye Bioscience Price Chart
Skye Bioscience SKYE Financial and Trading Overview
| Skye Bioscience stock price | 1.86 USD |
| Previous Close | 1.78 USD |
| Open | 1.77 USD |
| Bid | 1.39 USD x 200 |
| Ask | 2.32 USD x 200 |
| Day's Range | 1.77 - 1.95 USD |
| 52 Week Range | 1.64 - 39.92 USD |
| Volume | 183.11K USD |
| Avg. Volume | 71K USD |
| Market Cap | 8.24M USD |
| Beta (5Y Monthly) | 2.9 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.24 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 68 USD |
SKYE Valuation Measures
| Enterprise Value | -1649915 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.25135136 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.035 |
Trading Information
Skye Bioscience Stock Price History
| Beta (5Y Monthly) | 2.9 |
| 52-Week Change | -94.35% |
| S&P500 52-Week Change | 18.83% |
| 52 Week High | 39.92 USD |
| 52 Week Low | 1.64 USD |
| 50-Day Moving Average | 4.12 USD |
| 200-Day Moving Average | 6.2 USD |
SKYE Share Statistics
| Avg. Volume (3 month) | 71K USD |
| Avg. Daily Volume (10-Days) | 92.88K USD |
| Shares Outstanding | 4.43M |
| Float | 2.77M |
| Short Ratio | 2.92 |
| % Held by Insiders | 4.24% |
| % Held by Institutions | 44.49% |
| Shares Short | 150.45K |
| Short % of Float | 4.75% |
| Short % of Shares Outstanding | 3.40% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -95.055% |
| Return on Equity (ttm) | -233.87% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -47366696 USD |
| Net Income Avi to Common (ttm) | -50492576 USD |
| Diluted EPS (ttm) | -10.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.06M USD |
| Total Cash Per Share (mrq) | 2.27 USD |
| Total Debt (mrq) | 178.75K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.95 |
| Book Value Per Share (mrq) | -0.113 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -38810452 USD |
| Levered Free Cash Flow (ttm) | -18710042 USD |
Profile of Skye Bioscience
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 11250 El Camino Real |
| ZIP | 92130 |
| Phone | 858 410 0266 |
| Website | https://skyebioscience.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Skye Bioscience, Inc., a clinical-stage biotechnology company, develops molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related metabolic diseases. The company's lead clinical asset is nimacimab, a peripherally-restricted negative allosteric modulating antibody targeting cannabinoid receptor 1 (CB1) administered as a subcutaneous injectable, which targets CB1 receptors in peripheral tissues including adipose, liver, and muscle tissues with limited central nervous system accumulation. Nimacimab addresses metabolic processes related to energy expenditure, fat mobilization, leptin sensitivity, appetite regulation, and satiety signaling. Skye Bioscience, Inc. was formerly known as Emerald Bioscience Inc. and changed its name to Skye Bioscience, Inc. in December 2020. Skye Bioscience, Inc. was incorporated in 2011 and is based in San Diego, California.
Q&A For Skye Bioscience Stock
What is a current SKYE stock price?
Skye Bioscience SKYE stock price today per share is 1.86 USD.
How to purchase Skye Bioscience stock?
You can buy SKYE shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Skye Bioscience?
The stock symbol or ticker of Skye Bioscience is SKYE.
Which industry does the Skye Bioscience company belong to?
The Skye Bioscience industry is Biotechnology.
How many shares does Skye Bioscience have in circulation?
The max supply of Skye Bioscience shares is 4.43M.
What is Skye Bioscience Price to Earnings Ratio (PE Ratio)?
Skye Bioscience PE Ratio is now.
What was Skye Bioscience earnings per share over the trailing 12 months (TTM)?
Skye Bioscience EPS is -10.24 USD over the trailing 12 months.
Which sector does the Skye Bioscience company belong to?
The Skye Bioscience sector is Healthcare.
